"We conducted rigorous testing of our PR campaign. As we are a schedule four medicine, we aren't allowed to advertise or promote – thus we don't even have a website. Nor can we target our patients with direct mail or the like. It's clear that we can only attribute our impressive increase in recognition to our PR strategy which was quite complex as it covered surgeons, GPs and consumers."
Sarah Kennedy
GM – Q-Med Pharmaceuticals, Sweden
